FDA takes on GLP-1 compounding boom with warnings about misleading marketing Telehealth companies and other providers imply drugs are approved, letters say

https://www.statnews.com/2025/09/19/fda-obesity-semaglutide-tirzepatide-telehealth-warning-compounding-glp1/